Interplay of Genetic and Epigenetic Alterations in Hepatocellular Carcinoma

References

• El-Serag HB . Epidemiology of viral hepatitis and hepatocellular carcinoma . Gastroenterology142 ( 6 ), 1264 – 1273 . e1 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Farazi PA , DePinhoRA . Hepatocellular carcinoma pathogenesis: from genes to environment . Nat. Rev. Cancer6 ( 9 ), 674 – 687 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Nishida N , GoelA . Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review . Curr. Genomics12 ( 2 ), 130 – 137 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kawai-Kitahata F , AsahinaY , TanakaSet al. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features . J. Gastroenterology51 ( 5 ), 473 – 486 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tornesello ML , BuonaguroL , TatangeloF , BottiG , IzzoF , BuonaguroFM . Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections . Genomics102 ( 2 ), 74 – 83 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Hernandez-Vargas H , LambertMP , Le Calvez-KelmFet al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors . PLoS ONE5 ( 3 ), e9749 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Cornella H , AlsinetC , VillanuevaA . Molecular pathogenesis of hepatocellular carcinoma . Alcohol. Clin. Exp. Res.35 ( 5 ), 821 – 825 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Li M , ZhaoH , ZhangXet al. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma . Nat. Genet.43 ( 9 ), 828 – 829 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Hlady RA , TiedemannRL , PuszykWet al. Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis . Oncotarget5 ( 19 ), 9425 – 9443 ( 2014 ).
   PubMedGoogle Scholar
• Bressac B , KewM , WandsJ , OzturkM . Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa . Nature350 ( 6317 ), 429 – 431 ( 1991 ).
   PubMed Web of Science ®Google Scholar
• Schulze K , ImbeaudS , LetouzeEet al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets . Nat. Genet.47 ( 5 ), 505 – 511 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Sung WK , ZhengH , LiSet al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma . Nat. Genet.44 ( 7 ), 765 – 769 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Fujimoto A , TotokiY , AbeTet al. Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators . Nat. Genet.44 ( 7 ), 760 – 764 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Kan Z , ZhengH , LiuXet al. Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma . Genome Res.23 ( 9 ), 1422 – 1433 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Totoki Y , TatsunoK , CovingtonKRet al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes . Nat. Genet.46 ( 12 ), 1267 – 1273 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Schuster-Bockler B , LehnerB . Chromatin organization is a major influence on regional mutation rates in human cancer cells . Nature488 ( 7412 ), 504 – 507 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Heyn H , SayolsS , MoutinhoCet al. Linkage of DNA methylation quantitative trait loci to human cancer risk . Cell Rep.7 ( 2 ), 331 – 338 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Alexandrov LB , Nik-ZainalS , WedgeDCet al. Signatures of mutational processes in human cancer . Nature500 ( 7463 ), 415 – 421 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Saito Y , KanaiY , SakamotoM , SaitoH , IshiiH , HirohashiS . Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis . Hepatology33 ( 3 ), 561 – 568 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Sansom OJ , BishopSM , BirdA , ClarkeAR . MBD4 deficiency does not increase mutation or accelerate tumorigenesis in mice lacking MMR . Oncogene23 ( 33 ), 5693 – 5696 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• van de Klundert MA , van HemertFJ , ZaaijerHL , KootstraNA . The hepatitis B virus x protein inhibits thymine DNA glycosylase initiated base excision repair . PLoS ONE7 ( 11 ), e48940 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Pogribny IP , RusynI . Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma . Cancer Lett.342 ( 2 ), 223 – 230 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Nishida N , KudoM , NishimuraTet al. Unique association between global DNA hypomethylation and chromosomal alterations in human hepatocellular carcinoma . PLoS ONE8 ( 9 ), e72312 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Guichard C , AmaddeoG , ImbeaudSet al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma . Nat. Genet.44 ( 6 ), 694 – 698 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• He C , XuJ , ZhangJet al. High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma . Hum. Pathol.43 ( 9 ), 1425 – 1435 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Li H , AnJ , WuMet al. LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2 . Oncotarget6 ( 29 ), 27847 – 27864 ( 2015 ).
   PubMedGoogle Scholar
• Wong CM , LaiW , LawCTet al. upregulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis . Hepatology63 ( 2 ), 474 – 487 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Tian Y , YangW , SongJ , WuY , NiB . Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis . Mol. Cell. Biol.33 ( 15 ), 2810 – 2816 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lee SM , LeeYG , BaeJBet al. HBx induces hypomethylation of distal intragenic CpG islands required for active expression of developmental regulators . Proc. Natl Acad. Sci. USA111 ( 26 ), 9555 – 9560 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Saito Y , KanaiY , SakamotoM , SaitoH , IshiiH , HirohashiS . Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis . Proc. Natl Acad. Sci. USA99 ( 15 ), 10060 – 10065 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Chuang KH , Whitney-MillerCL , ChuCYet al. MicroRNA-494 is a master epigenetic regulator of multiple invasion-suppressor microRNAs by targeting ten eleven translocation 1 in invasive human hepatocellular carcinoma tumors . Hepatology62 ( 2 ), 466 – 480 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Yue F , ChengY , BreschiAet al. A comparative encyclopedia of DNA elements in the mouse genome . Nature515 ( 7527 ), 355 – 364 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Frau M , FeoF , PascaleRM . Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis . J. Hepatol.59 ( 4 ), 830 – 841 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nishida N , KudoM , NagasakaT , IkaiI , GoelA . Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma . Hepatology56 ( 3 ), 994 – 1003 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ammerpohl O , PratschkeJ , SchafmayerCet al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma . Int. J. Cancer130 ( 6 ), 1319 – 1328 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Shen J , WangS , ZhangYJet al. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips . Epigenetics8 ( 1 ), 34 – 43 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Villanueva A , PortelaA , SayolsSet al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma . Hepatology61 ( 6 ), 1945 – 1956 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Shen J , WangS , ZhangYJet al. Genome-wide DNA methylation profiles in hepatocellular carcinoma . Hepatology55 ( 6 ), 1799 – 1808 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Song MA , TiirikainenM , KweeS , OkimotoG , YuH , WongLL . Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma . PLoS ONE8 ( 2 ), e55761 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nishida N , NagasakaT , NishimuraT , IkaiI , BolandCR , GoelA . Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma . Hepatology47 ( 3 ), 908 – 918 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Stefanska B , HuangJ , BhattacharyyaBet al. Definition of the landscape of promoter DNA hypomethylation in liver cancer . Cancer Res.71 ( 17 ), 5891 – 5903 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Anestopoulos I , VoulgaridouGP , GeorgakilasAG , FrancoR , PappaA , PanayiotidisMI . Epigenetic therapy as a novel approach in hepatocellular carcinoma . Pharmacol. Ther.145 , 103 – 119 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lee SM , ChoiWY , LeeJ , KimYJ . The regulatory mechanisms of intragenic DNA methylation . Epigenomics7 ( 4 ), 527 – 531 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Wong IH , LoYM , ZhangJet al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients . Cancer Res.59 ( 1 ), 71 – 73 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Shibata T , AburataniH . Exploration of liver cancer genomes . Nat. Rev. Gastroenterol. Hepatol.11 ( 6 ), 340 – 349 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Naugler WE , KarinM . The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer . Trends Mol. Med.14 ( 3 ), 109 – 119 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Muriel P . Role of free radicals in liver diseases . Hepatol Int.3 ( 4 ), 526 – 536 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Yuan K , LeiY , ChenHNet al. HBV-induced ROS accumulation promotes hepatocarcinogenesis through Snail-mediated epigenetic silencing of SOCS3 . Cell Death Differ.23 ( 4 ), 616 – 627 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Viswanathan SR , DaleyGQ . Lin28: a microRNA regulator with a macro role . Cell140 ( 4 ), 445 – 449 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Giannitrapani L , SoresiM , BalasusD , LicataA , MontaltoG . Genetic association of interleukin-6 polymorphism (-174 G/C) with chronic liver diseases and hepatocellular carcinoma . World J. Gastroenterol.19 ( 16 ), 2449 – 2455 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Pikarsky E , PoratRM , SteinIet al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer . Nature431 ( 7007 ), 461 – 466 ( 2004 ).
   PubMed Web of Science ®Google Scholar
• Robertson CL , SrivastavaJ , SiddiqAet al. Genetic deletion of AEG-1 prevents hepatocarcinogenesis . Cancer Res.74 ( 21 ), 6184 – 6193 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhang Q , JiXW , HouXMet al. Effect of functional nuclear factor-kappaB genetic polymorphisms on hepatitis B virus persistence and their interactions with viral mutations on the risk of hepatocellular carcinoma . Ann. Oncol.25 ( 12 ), 2413 – 2419 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Mah WC , ThurnherrT , ChowPKet al. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis . PLoS ONE9 ( 8 ), e104158 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Wang K , LimHY , ShiSet al. Genomic landscape of copy number aberrations enables the identification of oncogenic drivers in hepatocellular carcinoma . Hepatology58 ( 2 ), 706 – 717 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Motalleb G , GholipourN , SamaeiNM . Association of the human astrocyte elevated gene-1 promoter variants with susceptibility to hepatocellular carcinoma . Med. Oncol.31 ( 4 ), 916 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Aleem E , NehrbassD , KlimekF , MayerD , BannaschP . Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis . Toxicol. Pathol.39 ( 3 ), 524 – 543 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ou DL , LeeBS , ChangYCet al. Potentiating the efficacy of molecular targeted therapy for hepatocellular carcinoma by inhibiting the insulin-like growth factor pathway . PLoS ONE8 ( 6 ), e66589 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Enguita-German M , FortesP . Targeting the insulin-like growth factor pathway in hepatocellular carcinoma . World J. Hepatol.6 ( 10 ), 716 – 737 ( 2014 ).
   PubMedGoogle Scholar
• Alter D , GrenacheDG , BoslerDSet al. Check sample abstracts . Am. J. Clin. Pathol.131 ( 2 ), 286 – 299 ( 2009 ).
   PubMedGoogle Scholar
• Hanafusa T , YumotoY , NousoKet al. Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma . Cancer Lett.176 ( 2 ), 149 – 158 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Sandhu DS , BaichooE , RobertsLR . Fibroblast growth factor signaling in liver carcinogenesis . Hepatology59 ( 3 ), 1166 – 1173 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Goyal L , MuzumdarMD , ZhuAX . Targeting the HGF/c-MET pathway in hepatocellular carcinoma . Clin. Cancer Res.19 ( 9 ), 2310 – 2318 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Muller PA , VousdenKH . p53 mutations in cancer . Nat. Cell Biol.15 ( 1 ), 2 – 8 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Muller PA , VousdenKH . Mutant p53 in cancer: new functions and therapeutic opportunities . Cancer Cell25 ( 3 ), 304 – 317 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Fei Q , ShangK , ZhangJet al. Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53 . Nat. Commun.6 , 8651 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Zhang C , GuoX , JiangGet al. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma . Int. J. Cancer123 ( 5 ), 998 – 1004 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Jablkowski M , BocianA , BialkowskaJ , BartkowiakJ . A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma . J. Exp. Clin. Cancer Res.24 ( 1 ), 117 – 125 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Chan C , WangY , ChowPK , ChungAY , OoiLL , LeeCG . Altered binding site selection of p53 transcription cassettes by hepatitis B virus X protein . Mol. Cell. Biol.33 ( 3 ), 485 – 497 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Kuo KK , JianSF , LiYJet al. Epigenetic inactivation of transforming growth factor-beta1 target gene HEYL, a novel tumor suppressor, is involved in the P53-induced apoptotic pathway in hepatocellular carcinoma . Hepatol. Res.45 ( 7 ), 782 – 793 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hinrichsen I , KempM , Peveling-OberhagJet al. Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs . PLoS ONE9 ( 1 ), e84453 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Zhu AX , DudaDG , SahaniDV , JainRK . HCC and angiogenesis: possible targets and future directions . Nat. Rev. Clin. Oncol.8 ( 5 ), 292 – 301 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wang W , MaXP , ShiZet al. Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma . Am. J. Cancer Res.5 ( 1 ), 396 – 410 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Nhieu JT , RenardCA , WeiY , CherquiD , ZafraniES , BuendiaMA . Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation . Am. J. Pathol.155 ( 3 ), 703 – 710 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Lei ZJ , WangJ , XiaoHLet al. Lysine-specific demethylase 1 promotes the stemness and chemoresistance of Lgr5+ liver cancer initiating cells by suppressing negative regulators of beta-catenin signaling . Oncogene34 ( 24 ), 3214 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ding SL , YangZW , WangJ , ZhangXL , ChenXM , LuFM . Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma . World J. Gastroenterol.21 ( 20 ), 6317 – 6328 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Lee JS . The mutational landscape of hepatocellular carcinoma . Clin. Mol. Hepatol.21 ( 3 ), 220 – 229 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Nault JC , MalletM , PilatiCet al. High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions . Nat. Commun.4 , 2218 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Zhang H , WengX , YeJ , HeL , ZhouD , LiuY . Promoter hypermethylation of TERT is associated with hepatocellular carcinoma in the Han Chinese population . Clin. Res. Hepatol. Gastroenterol.39 ( 5 ), 600 – 609 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Hager KM , GuW . Understanding the non-canonical pathways involved in p53-mediated tumor suppression . Carcinogenesis35 ( 4 ), 740 – 746 ( 2014 ).
   PubMed Web of Science ®Google Scholar